Abstract
Naturally occurring autoantibodies (NAbs) are typically polyreactive, bind with low affinity to a discrete set of autoantigens and are encoded by variable region genes in germline configuration. They differ from disease-associated autoantibodies (autoAb), which are mostly monoreactive, somatically mutated and of high affinities. Structure-function studies have shown that polyreactivity of NAbs relies on the somatically generated complementarity determining region, CDR3, of the heavy chain. This finding suggested that NAb-producing B cells were positively selected from the pre-immune B-cell repertoire. The biological significance of this selection remains, however, unclear. Data originating mainly from transgenic mice have shown that mature NAb-producing B cells are frequently ignorant toward their antigen, possibly due to their low affinity, though active tolerance mechanisms are not excluded. An important issue is whether NAb-producing B cells constitute the pool from which pathologic auto Ab emerge after autoantigen-driven maturation. We summarize results obtained in mouse models, showing that some infectious agents are able to induce an autoantigen-driven activation of certain NAb-producing B cells. However direct proof that selection by autoantigen may lead to somatic hypermutation are still lacking. Other data tend to suggest that pathologic auto Abs may derive from non-autoimmune B cells that have diversified by somatic hypermutation of their variable region genes.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Dighiero G, Lymberi P, Guilbert B et al. Natural autoantibodies constitute a substantial part of normal circulating immunoglobulins. Ann N Y Acad Sci 1986; 475:135–45. PMID:3466566 doi:10.1111/j. 1749-6632.1986. tb20863.x
Coutinho A, Kazatchkine MD, Avramaes S. Natural Autoantibodies. Curr Opin Immunol 1995; 7:812–8. PMID:8679125 doi:10.1016/0952-7915(95)80053-0
Zelenay S, Moraes-Fontes MF, Fesel C et al. Physiopathology of natural autoantibodies: the case for regulation. J Autoimmun 2007; 29:229–35. PMID: 17967665 doi:10.1016/j.jaut.2007.07.011
Wardemann H, Yurasov S, Schaefer A et al. Predominant autoantibody production by early human B cell precursors. Science 2003; 301:1374–7. PMID:12920303 doi: 10.1126/science. 1086907
Radic MZ, Weigert M. Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu Rev Immunol 1994; 12:487–520. PMID:8011289 doi: 10.1146/annurev.iy. 12.040194.002415
Shlomchik MJ, Marshak-Rothstein A, Wolfowicz CB et al. The role of clonal selection and somatic mutation in auto-immunity. Nature 1987; 328:805–11. PMID:3498121 doi:10.1038/328805a0
Lieby P, Poindron V, Roussi S et al. Pathogenic antiphospholipid antibody: an antigen-selected needle in a haystack. Blood 2004; 104:1711–5. PMID:15166038 doi:10.1182/blood-2004-02-0462
Casali P, Notkins AL. CD5+B lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunol Today 1989; 10:364–8. PMID:2482031 doi: 10.1016/0167-5699(89)90268-5
Martin T, Duffy SF, Carson DA et al. Evidence for somatic selection of natural autoantibodies. J Exp Med 1992; 175:983–91. PMID:1552291 doi: 10.1084/jem. 175.4.983
Martin T, Crouzier R, Weber JC et al. Structure-function studies on a polyreactive (Natural) autoantibody. Polyreactivity is dependent on somatically generated sequences in the third complementarity-determining region of the antibody heavy chain. J Immunol 1994; 152:5988–96. PMID:8207223
Crouzier R, Martin T, Pasquali JL. Heavy chain variable region, light chain variable region and heavy chain CDR3 influences on the mono and polyreactivity and on the affinity of human monoclonal rheumatoid factors. J Immunol 1995; 154:4526–35. PMID:7722307
Ichiyoshi Y, Casali P. Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segments. J Exp Med 1994; 180:885–95. PMID:8064239 doi:10.1084/jem.l80.3.885
Köhler F, Hug E, Eschbach C et al. Autoreactive B cell receptors mimic autonomous pre-B cell receptor signaling and induce proliferation of early B cells. Immunity 2008; 29:912–21. PMID: 19084434 doi:10.1016/j.immuni.2008.10.013
Hayakawa K, Asano M, Shinton SA et al. Positive selection of natural autoreactive B cells. Science 1999; 285:113–6. PMID: 10390361 doi:10.1126/science.285.5424.113
Julien S, Soulas P, Garaud JC et al. B cell positive selection by soluble self-antigen. J Immunol 2002; 169:4198–204. PMID: 12370349
Wang H, Clarke SH. Evidence for a ligand-mediated positive selection signal in differentiation to a mature B cell. J Immunol 2003; 171:6381–8. PMID:14662836
Wang H, Clarke SH. Positive selection focuses the VH12 B-cell repertoire towards a single B1 specificity with survival function. Immunol Rev 2004; 197:51–9. PMID:14962186 doi: 10.1 lll/j.0105-2896.2004.0098.x
Ohnishi K, Melchers F. The nonimmunoglobulin portion of Iambda5 mediates cell-autonomous pre-B cell receptor signaling. Nat Immunol 2003; 4:849–56. PMID: 12897780 doi:10.1038/ni959
Koralov SB, Novobrantseva TI, Konigsmann J et al. Antibody repertoires generated by VH replacement and direct VH to JH joining. Immunity 2006; 25:43–53. PMID: 16860756 doi: 10.1016/j.immuni.2006.04.016
Gauthier L, Rossi B, Roux F et al. Galectin-1 is a stromal cell ligand of the pre-B cell receptor (BCR) implicated in synapse formation between pre-B and stromal cells and in pre-BCR triggering. Proc Natl Acad Sci USA 2002; 99:13014–9. PMID: 12271131 doi: 10.1073/pnas.202323999
Bradl H, Wittmann J, Milius D et al. Interaction of murine precursor B cell receptor with stroma cells is controlled by the unique tail of lambda 5 and stroma cell-associated heparin sulfate. J Immunol 2003; 171:2338–48. PMID:12928380
Hardy RR. B-1 cells development, selection, natural autoantibody and leukemia. Curr Opin Immunol 2006; 18:547–55. PMID: 16879952 doi:10.1016/j.coi.2006.07.010
Von Boehmer H, Melchers F. Checkpoints in lymphocyte development and autoimmune disease. Nat Immunol 2010; 11:14–20. PMID:20016505 doi:10.1038/ni.1794
Pasquali JL, Soulas-Sprauel P, Korganow AS et al. Auto-reactive B cells in transgenic mice. J Autoimmun 2007; 29:250–6. PMID:17845841 doi:10.1016/j.jaut.2007.07.006
Shlomchik MJ, Zharhary D, Saunders T et al. A rheumatoid factor transgenic mouse model of autoantibody regulation. Int Immunol 1993; 5:1329–41. PMID:8268138 doi:10.1093/intimm/5.10.1329
Koenig-Marrony S, Soulas P, Julien S et al. Natural autoreactive B cells in transgenic mice reproduce an apparent paradox to the clonal tolerance theory. J Immunol 2001; 166:1463–70. PMID:11160185
Aplin BD, Keech CL, de Kauwe AL et al. Tolerance through indifference: autoreactive B cells to the nuclear antigen La show no evidence of tolerance in a transgenic model. J Immunol 2003; 171:5890–900. PMID: 14634099
Hannum LG, Ni D, Haberman AM et al. A disease-related rheumatoid factor autoantibody is not tolerized in a normal mouse: implications for the origins of autoantibodies in autoimmune disease. J Exp Med 1996; 184:1269–78. PMID:8879198 doi: 10.1084/jem. 184.4.1269
Soulas P, Koenig-Marrony S, Julien S et al. A role for membrane IgD in the tolerance of pathological human rheumatoid factor B cells. Eur J Immunol 2002; 32:2623–34. PMID: 12207347 doi: 10.1002/1521-4141(200209)32:9<2623∷AID-IMMU2623>3.0.CO;2-0
Cariappa A, Tang M, Parng C et al. The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. Immunity 2001; 14:603. PMID:11371362 doi:10.1016/S1074-7613(01)00135-2
Soulas P, Woods A, Jaulhac B et al. Autoantigen, innate immunity, and T cells cooperate to break B cell tolerance during bacterial infection. J Clin Invest 2005; 115:2257–67. PMID:16041408 doi:10.1172/JCI24646
Hansen KE, Arnason J, Bridges AJ. Autoantibodies and common viral illnesses. Semin Arthritis Rheum 1998; 27:263–71. PMID:9572708 doi:10.1016/S0049-0172(98)80047-4
Ludewig B, Krebs P, Metters H et al. Molecular characterization of virus-induced autoantibody responses. J Exp Med 2004; 200:637–46. PMID: 15353556 doi:10.1084/jem.20040358
Hunziker L, Recher M, Macpherson AJ et al. Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections. Nat Immunol 2003; 4:343–9. PMID: 12627229 doi:10.1038/ni911
Bernasconi NL, Traggiai E, Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002; 298:2199–202. PMID: 12481138 doi: 10.1126/science. 1076071
Recher M, Hunziker L, Ciurea A et al. Public, private and non-specific antibodies induced by non-cytopathic viral infections. Curr Opin Microbiol 2004; 7:426–33. PMID:15358263 doi:10.1016/j.mib.2004.06.008
Jellison ER, Guay HM, Szomolanyi-Tsuda E et al. Dynamics and magnitude of virus-induced polyclonal B cell activation mediated by BCR-independent presentation of viral antigen. Eur J Immunol 2007; 37:119–28. PMID:17163452 doi:10.1002/eji.200636516
Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010; 11:373–84. PMID:20404851 doi:10.1038/ni.l863
Woods A, Soulas-Sprauel P, Jaulhac B et al. MyD88 negatively controls hypergammaglobulinemia with autoantibody production during bacterial infection. Infect Immun 2008; 76:1657–67. PMID: 18227170 doi:10.1128/IAI.00951-07
Bolz DD, Sundsbak RS, Ma Y et al. MyD88 plays a unique role in host defense but not arthritis development in Lyme disease. J Immunol 2004; 173:2003–10. PMID: 15265935
Alexopoulou L, Thomas V, Schnare M et al. Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1-and TLR2-deficient mice. Nat Med 2002; 8:878–84. PMID: 12091878
Roosnek E, Lanzavecchia A. Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B cells. J Exp Med 1991; 173:487–9. PMID:1703209 doi: 10.1084/jem. 173.2.487
Leadbetter EA, Rifkin IR, Hohlbaum AM et al. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 2002; 416:603–7. PMID: 11948342 doi:10.1038/416603a
Lau CM, Broughton C, Tabor AS et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J Exp Med 2005; 202:1171–7. PMID: 16260486 doi:10.1084/jem.20050630
Viglianti GA, Lau CM, Hanley TM et al. Activation of autoreactive B cells by CpG dsDNA. Immunity 2003; 19:837–47. PMID: 14670301 doi:10.1016/S1074-7613(03)00323-6
Berland R, Fernandez L, Kari E et al. Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice. Immunity 2006; 25:429–40. PMID: 16973388 doi: 10.1016/j. immuni.2006.07.014
Gilkeson GS, Pippen AM, Pisetsky DS. Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZB/NZW mice by immunization with bacterial DNA. J Clin Invest 1995; 95:1398–402. PMID:7883986 doi:10.1172/JCI117793
Rui L, Vinuesa CG, Blasioli J et al. Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling. Nat Immunol 2003; 4:594–600. PMID: 12740574 doi: 10.1038/ni924
Guo W, Smith D, Aviszus K et al. Somatic hypermutation as a generator of antinuclear antibodies in a murine model of systemic autoimmunity. J Exp Med 2010; 207:2225–37. PMID:20805563 doi: 10.1084/jem.20092712
Vinuesa CG, Sanz I, Cook MC. Dysregulation of germinal centres in autoimmune disease. Nat Rev Immunol 2009; 9:845–57. PMID:19935804 doi:10.1038/nri2637
Lieby P, Soley A, Knapp AM et al. Memory B cells producing somatically mutated antiphospholipid antibodies are present in healthy individuals. Blood 2003; 102:2459–65. PMID:12791657 doi:10.1182/blood-2003-01-0180
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Landes Bioscience and Springer Science+Business Media
About this chapter
Cite this chapter
Pasquali, J.L., Martin, T. (2012). Control of B Cells Expressing Naturally Occurring Autoantibodies. In: Lutz, H.U. (eds) Naturally Occurring Antibodies (NAbs). Advances in Experimental Medicine and Biology, vol 750. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-3461-0_11
Download citation
DOI: https://doi.org/10.1007/978-1-4614-3461-0_11
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-3460-3
Online ISBN: 978-1-4614-3461-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)